Search hospitals > Quebec > MONTREAL
The Montreal Children's Hospital of the MUHC
Claim this profileMONTREAL, Quebec H3H 1P3
Global Leader in Adult T-Cell Leukemia/Lymphoma
Global Leader in Cancer
Conducts research for Brain Tumor
Conducts research for Acute Lymphoblastic Leukemia
Conducts research for Leukemia
254 reported clinical trials
12 medical researchers
Summary
The Montreal Children's Hospital of the MUHC is a medical facility located in MONTREAL, Quebec. This center is recognized for care of Adult T-Cell Leukemia/Lymphoma, Cancer, Brain Tumor, Acute Lymphoblastic Leukemia, Leukemia and other specialties. The Montreal Children's Hospital of the MUHC is involved with conducting 254 clinical trials across 495 conditions. There are 12 research doctors associated with this hospital, such as Sharon B. Abish, Genevieve Legault, MD, Pia Wintermark, MD, and Catherine Vezina, MD.Area of expertise
1Adult T-Cell Leukemia/Lymphoma
Global LeaderStage II
BCR-ABL1 fusion positive
ABL-class fusion positive
2Cancer
Global LeaderStage IV
Stage I
Stage II
Top PIs
Sharon B. AbishThe Montreal Children's Hospital of the MUHC5 years of reported clinical research
Studies Cancer
Studies Adult T-Cell Leukemia/Lymphoma
29 reported clinical trials
74 drugs studied
Genevieve Legault, MDMontreal Children's Hospital1 year of reported clinical research
Studies Brain Tumor
Studies Diffuse Intrinsic Pontine Glioma
8 reported clinical trials
12 drugs studied
Pia Wintermark, MDMontreal Children's Hospital5 years of reported clinical research
Studies Brain Injury
Studies Birth Asphyxia
2 reported clinical trials
2 drugs studied
Catherine Vezina, MDThe Montreal Children's Hospital (MUHC-McGill)9 years of reported clinical research
Studies Adult T-Cell Leukemia/Lymphoma
Studies Acute Lymphoblastic Leukemia
2 reported clinical trials
3 drugs studied
Clinical Trials running at The Montreal Children's Hospital of the MUHC
Brain Tumor
Testicular cancer
Diffuse Intrinsic Pontine Glioma
Neuroblastoma
Cancer
Testicular Carcinoma
Acute Lymphoblastic Leukemia
Glioblastoma
Brain Cancer
Germ Cell Tumors
Metformin
for Medulloblastoma Recovery
The efficacy of treatment with metformin for promoting cognitive recovery and brain growth in children/adolescents treated for a brain tumour will be investigated in a multi-site Phase III randomized double-blind placebo-controlled parallel arm superiority trial. Specifically, in children/adolescents aged 7 years to 21 years and 11 months who have completed treatment for a brain tumour, is oral administration of metformin for 16 weeks associated with greater improvement of cognitive function and brain growth compared to placebo administered for 16 weeks?
Recruiting3 awards Phase 312 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Lower Radiotherapy Dose
for Brain Tumors
This phase II trial studies how well lower dose radiotherapy after chemotherapy (Carboplatin \& Etoposide) works in treating children with central nervous system (CNS) germinomas. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. Researchers want to see if lowering the dose of standard radiotherapy (RT) after chemotherapy can help get rid of CNS germinomas with fewer long-term side effects.
Recruiting1 award Phase 210 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at The Montreal Children's Hospital of the MUHC?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.